Sign in
4

Changes in Ownership

TherapeuticsMD, Inc. Filed Acc 0001209191-22-060587

General Counsel sold 1,048 shares at $4.95 ($5,185)

  • General Counsel acquired 2,554 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Walker Marlan D · General Counsel

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-06 Exercise or conversion : show line 1 in the form +1,010 6,189 D
2022-12-06 Exercise or conversion : show line 2 in the form +1,156 7,345 D
2022-12-06 Exercise or conversion : show line 3 in the form +388 7,733 D
2022-12-06 Sale : show line 4 in the form −1,048 $4.95 $5,185 6,685 D
Open-market sales · 1,048 sh · avg $4.95 · $5,185

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-12-06 Exercise or conversion : show line 5 in the form Restricted Stock Unit −1,010 1,010 D
2022-12-06 Exercise or conversion : show line 6 in the form Restricted Stock Unit −1,156 2,311 D
2022-12-06 Exercise or conversion : show line 7 in the form Restricted Stock Unit −388 770 D
Loading xslF345X03/doc4.xml…